Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing Clopidogrel and Cilostazol in Type 2 Diabetes Patients With Carotid Atherosclerosis
NCT06402747Phase 4Recruiting
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, cilostazol in atherosclerosis, sponsored by Seoul National University Bundang Hospital. Started Apr 2024; status: recruiting.
02
Drugs
clopidogrelcilostazol
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT06402747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06402747.